Particularly, mouse monoclonal R24 antibody (IgG3), directed against ganglioside GD3, is a validated tumor targeting agent that shows strong cell surface reactivity with a range of human melanoma cell lines and other epithelial cancer tumor cells [7]. The gene discussed is IGHG3; the disease is neoplasm.